using compounded semaglutide after 28 days FDA Warns on Certain Forms of Compounded Semaglutide After 28 Days:

Facial fat pads shrinking can lead to: a hollowed cheeks or sunken appearance under-eye hollows in face tissue thickness skin folds or deep facial ridges loose skin on your chin or jawline Rapid weight loss from GLP-1 drugs may highlight facial changes

While many drugs in this class were initially approved to treat type 2 diabetes, they have also been approved for weight loss

It was the first time anything in recent memory had bent that curve at a national scale

But the early trajectory is compelling

If more than 5 days late, skip the missed dose and resume as planned

However, not all triple GLP-1/GIP/GCG agonists are advancing to late-stage clinical trials